Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BTR-1 (5-Benzylidene-3-ethyl rhodanine) 是一种活性抗癌剂, 可激活细胞凋亡并诱导细胞死亡。它能够诱导细胞周期 S 期停滞,影响 DNA 复制。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 473 | 现货 | ||
2 mg | ¥ 688 | 现货 | ||
5 mg | ¥ 1,190 | 现货 | ||
10 mg | ¥ 1,930 | 现货 | ||
25 mg | ¥ 3,620 | 现货 | ||
50 mg | ¥ 5,230 | 现货 | ||
100 mg | ¥ 7,390 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,090 | 现货 |
产品描述 | 5-Benzylidene-3-ethyl rhodanine(BTR-1 (5-Benzylidene-3-ethyl rhodanine)) is an active anti-cancer agent. BTR-1 activates apoptosis and induces cell death. |
体外活性 | 5-isopropylidiene derivatives of 3-dimethyl-2-thio-hydantoin (ITH-1), 3-ethyl-2-thio-2,4-oxazolidinedione (ITO-1), and 5-Benzylidene-3-ethyl rhodanine(BTR-1), and have tested their chemotherapeutic properties. All three compounds induced cytotoxicity in a time- and concentration-dependent manner on leukemic cell line, CEM. Among the compounds tested, BTR-1 was 5- to 7-fold more potent than ITH-1 and ITO-1 when compared by trypan blue and MTT assays. IC(50) value of BTR-1 was estimated to be <10μM. Both cell cycle analysis and tritiated thymidine assays revealed that BTR-1 affects DNA replication by inducing a block at S phase. BTR-1 treatment led to increased level of ROS production and DNA strand breaks suggesting activation of apoptosis for induction of cell death. |
别名 | 5-Benzylidene-3-ethyl rhodanine |
分子量 | 249.35 |
分子式 | C12H11NOS2 |
CAS No. | 18331-34-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (100.26 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.0104 mL | 20.0521 mL | 40.1043 mL | 100.2607 mL |
5 mM | 0.8021 mL | 4.0104 mL | 8.0209 mL | 20.0521 mL | |
10 mM | 0.401 mL | 2.0052 mL | 4.0104 mL | 10.0261 mL | |
20 mM | 0.2005 mL | 1.0026 mL | 2.0052 mL | 5.013 mL | |
50 mM | 0.0802 mL | 0.401 mL | 0.8021 mL | 2.0052 mL | |
100 mM | 0.0401 mL | 0.2005 mL | 0.401 mL | 1.0026 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BTR-1 18331-34-5 Apoptosis Inhibitor inhibit 5-Benzylidene-3-ethyl rhodanine BTR1 BTR 1 inhibitor